BiomX’s $15 Million Raising Fund

Gornitzky & Co. represented BiomX in the deal.

BiomX raised $15 million in a transaction under which a number of investors invested through placement agents (Cantor and Chardan).

BiomX, a Delaware company that is traded in the New York Stock Exchange and in the Tel Aviv Stock Exchange, is developing treatments that use bacteria-attacking viruses to treat a variety of illnesses.

The Gornitzky team was led by partner Shy Barnov (Picture), Associates Rebecca Genis and Yarden Wulkan Rozenman.

Involved fees earner: Shy Barnov – Gornitzky & Co.; Rebecca Genis – Gornitzky & Co.; Yarden Wulkan Rozenman – Gornitzky & Co.;

Law Firms: Gornitzky & Co.;

Clients: BiomX;

Leave a Reply